Brief: Cue Biopharma Announces Strategic Organizational Transition
14/11/2024 13:20
Nov 14 (Reuters) - Cue Biopharma Inc CUE.O :
* CUE BIOPHARMA ANNOUNCES STRATEGIC ORGANIZATIONAL
TRANSITION
* CUE BIOPHARMA INC: DANIEL BAKER WILL JOIN AS INTERIM CHIEF
DEVELOPMENT OFFICER
Source text: ID:nGNX7ww37y
Further company coverage: CUE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cue Biopharma
See all newsU.S. STOCKS ON THE MOVE-Insmed, Marvell, Meta
US STOCKS ON THE MOVE-Meta, Marvell Technology, Insmed
U.S. STOCKS ON THE MOVE-Accenture, Arhaus, Alkermes
Cue Biopharma surges after positive results from mid-stage study for CUE-221
Brief: Cue Biopharma Announces Positive Topline Results From Cue-221 Phase 2 Study In Chronic Spontaneous Urticaria